Meeting · chair Daniel
10:00, Monday, 22 June 2026.
They voted to ratify a seat already filled. GILD proposal #61 carried 4-0 [turns 560–563], but read it for what it is: a bookkeeping motion on a 1.0% starter that printed three days ago (79 shares @ $124.21, now -0.36% since entry, +0.7bps active contribution). Margaret sponsored it [turn 560] on the franchise — FY25 operating margin 39%, $10B cash flow, ROE 43%, forward PE around 15 — and the room nodded it through in four ayes without debate. Daniel [turn 561] called it "half-size is the honest size," because the 2.0% conviction weight won't clear the 0.90 beta floor and he's killed the ETN lever five times now on his own triggers. Priya [turn 562] confirmed the frame: reals at a fresh cycle-high 2.23, low-vol firmly ON. Iris [turn 563] bounded the loss path at about $1.5k on a -15% gap. Seventeen minutes, gavel [turn 564].
The real agenda was the thing they didn't vote on. Margaret worked four high-beta candidates to unlock GILD's second 1.0% — GS (sitting at its 52-week high, +22% in two months, "a chase, not a dislocation"), FDX (the right name at the right price but it prints fiscal Q4 tomorrow so the earnings-gap freeze blocks it tonight), EMR (no dislocation at 34x), SCHW and APD (don't clear the beta floor). She filed zero [turn 554]. Daniel ran the full gate against the live book [turn 553] and every path that tops GILD or another low-vol name solo pushes beta under 0.90 — the only clearing structure is a NEW high-beta active name (β≥1.15) seated WITH the defensive leg, and it isn't sourced yet. So GILD's second 1.0% stays "pre-committed and unfiled" (Daniel's phrase from three bulletins now), and the campaign toward 18 names pauses at ten.
The discipline is this: they didn't fake beta room with the ETN lever into cycle-high reals, and they didn't chase GS at a 52-week high because the math clears. They sized what the floor allowed and tabled the rest. You watch enough of these and the veto comes before the vote — this one came three days ago, and today was just the paperwork.
Book to ten active names, NAV $985.4K, beta 0.9018 on the 0.90 floor for the fifth straight session, SPY at 79.5%. The unlock to watch: FDX prints tomorrow (est $5.95); a soft-quarter gap toward the high-$280s unlocks GILD's leg and they size+pair it same session. A gap-up beat sends them back to the GS pile, but they want a pullback, not the high. Frame unchanged, low-vol ON, campaign paused on a tape gap.
Transcript
Good morning. Book's at $985.4K NAV, ten names, beta 0.9018 — pinned hard on the 0.90 floor again. Cash under 2%, SPY core still 79.5% and carrying the inception drag. One pending proposal on the agenda; we table, discuss, vote, and trade it today. I'm handing to Ops for the book brief, then to Priya for the macro frame. Hold your names until PROPOSE — let's keep it tight. We'll drive the phases in order.
brief 06-19. book 10 active, nav 985,439, no orders on the floor. since last meeting flat both sides — book doesn't trade between sit-downs so excess +0bps, no surprise. last week's sequence settled clean: gild 1.0pct starter in, pep trim and a 13.25sh spy clip funded it. concentration the room should eyeball: spy still 79.50pct, top-3 85.2pct, top-5 dead on the 90.00pct cap — no headroom to add a sixth heavy name without a trim. cash 1.56pct, lifted off the old 0.41pct pin by the pep sell but still ~44bps short of the 2pct floor, iris flag 21 still warn. beta 0.9018 glued to the 0.90 floor — every low-vol name the frame wants pushes it under, that wall's unchanged. financials +5.3pp the deepest tilt, single biggest deliberate bet. detractors are spy core, cme, xom; only v and etn green. no rejects, halts, breaks. chair, it's yours.
FRAME. We set the regime and the factor stance before any name moves — frame first, selection second. Book is ten names, beta 0.9018 pinned on the 0.90 floor, SPY core 79.5% carrying the inception drag (-102bps), cash 1.6%. Financials +5.3pp over SPY and band-binding; Energy +1.1pp into rolling oil. Same wall as last five sit-downs: the dead core, not selection.
Priya — macro regime read first: rates, reals, the curve, credit, vol. Then me on sector/factor stance. Iris on the risk envelope — beta floor, concentration, sector bands. Margaret on themes she's watching. Tight and declarative.
Handing to Priya.
Rates: 10-year 4.49, 2-year up to 4.20 — and 10-year reals snapped back to 2.23, a fresh cycle high (from 2.14 last week). Real rates are still tightening; low-vol stays ON, nowhere near my 1.90 ease trigger. 2s10s flattened again to 27bps (from 29) — the curve keeps pulling cuts forward without pricing growth. Funds 3.63, FOMC parked, on hold.
Dollar/oil: broad USD eased to 119.5 off the 120 high — firm, no reflation signal. WTI down to $84.65 (from ~$95), the energy-hedge accelerant continuing to deflate. Helps headline CPI; does nothing for shelter/services stickiness.
Credit/vol: HY OAS tightened to 263 — dead complacent, the tightest read of the cycle. VIX faded to 16.8, June pop fully unwound. This is equity-vol noise, not credit stress.
What changed from last week: reals re-tightened to a new high while credit got more complacent and vol drained — a late-cycle squeeze, not a turn. Tilt unchanged: low-vol ON, cash-flow-today over multiple, quality over junk. Carry ETN as the beta lever; don't lean cyclical into rolling oil and restrictive reals. Label: late-cycle defensive, complacent credit.
FRAME — riding Priya 06-22: late-cycle, reals snap to fresh cycle high 2.23, 2s10s 27bps flattening (cuts pulled forward, not growth), OAS 263 dead-complacent, VIX 16.8. Low-vol stays ON — NOT through the 1.90 ease trigger. No regime turn, no factor rotation this week.
Gross / cash: Hold. 79.5% SPY core + ~20% active gross, cash 1.6%. Gross is fine; the problem is the composition of gross, not the level. The 80% beta-1.0 core is -102bps of our -146bps inception drag. The campaign is unchanged: rotate dead SPY core into named active selection toward the 18-name floor (we're at 10).
Beta: 0.9018, pinned on the 0.90 floor — fifth meeting running. Structural wall, not selection. ETN (1.24) is our only high-beta active leg and a name I won't lever into reals-at-cycle-high. So every low-vol name still seats under 0.90 solo, and honest funding is a SPY trim, not an ETN jam.
Sector stance:
- Financials +5.3pp, band-binding — do not add. CME -16bps and SPGI -10.6bps are the active bleed; V (+9.7 active) is the carry. Happy with V, not with the sleeve size.
- Energy +1.1pp into rolling oil ($84.65, -11%) — XOM -12.5 active, the hedge is deflating. Do not add cyclical here.
- Health Care 12.1% ≈ neutral, room for one more named cash-flow leg.
- Staples +2.0pp — fine, don't deepen.
- IT -6.4pp underweight is the largest active sector cost (-6.2 active) but it's structural to the low-vol tilt; I accept it.
Factor I'm sponsoring: quality + cash-flow-today + low-vol, short-duration over multiple. Unchanged.
Where I want the book to move: SPY→selection. The unlock I've named since #47 still binds — we need a higher-beta quality name (cyclical or financial outside the binding sleeve) to open the beta budget so the next low-vol leg can seat ≥0.90 as a pair. Margaret sources; I size and pair.
Triggers: OAS>350 trims the cyclical leg first; reals<1.90 + 10yr<4.30 eases low-vol and migrates the ETN lever right-side. FRAME only — no filing this phase.
Live gate, read fresh. The one hard veto is the single-name cap, 0.5%-3.5% of NAV. Nothing is creeping: V is the largest active name at 3.11%, ETN 2.59% — roughly 40bps and 90bps of room. No single name threatens the gate this week.
The operative constraint is cash, not concentration. We're at 1.55%, under the 2% floor by ~$4.4k. The gate is direction-aware, so a name that nets cash-positive clears, but any net-buy worsens it and trips. Whatever gets pitched needs a funding leg attached or it doesn't seat.
What policy WON'T catch and the room must own: Financials at 18.3%, +5.3pp over SPY, ~1.4x and band-binding against the 1.6x cap — our biggest active bet and biggest drag at -14.6bps inception. That's a deliberate tilt, not an accident; someone should want it on purpose before we add to it.
Flag I'd call mid-week: CME is -6.39% inception, ~1360bps from the -2000bps review trip — another leg down and it's back to committee.
My theme is unchanged and it's the right theme for Priya's tape: cash-flow yield the market has divorced from the franchise, bought when the tape — not the business — breaks. Reals at a fresh 2.23 cycle high and OAS at 263 say own cash today, not multiple later. Two threads I'm researching. First, the patent-cliff discount in large-cap pharma — BMY at fwd PE ~9 on $14B+ OCF is the cleanest, and ABBV has finally come in to ~$212 (50d), inside hailing distance of my $205-210 zone after sitting near $239 — print 07-30, I want the pullback to finish before I act. Second, deep-value Staples (GIS at 8x, 7% yield) where the dislocation is real but the band is full. On the book: BMY conviction holds at 4 despite -4.3% — that's tape, not thesis. CME is the one that nags me — down 6.4%, -13.5bps active; I owe the room a thesis-vs-tape check before I defend it. GILD starter intact, working as a clearing leg.
PROPOSE. Floor's open — Margaret first, then me, Priya, Iris. We table a few names, debate them properly, vote this session. The book gets built across meetings, not in one morning.
Margaret's two live threads are GILD's pre-committed second 1.0% leg and the high-beta quality name I've been asking her to source. I ran the gate against the live book (beta 0.9018, dead on the 0.90 floor) before tabling anything, and the verdict is unambiguous:
| GILD second-leg path | resulting beta | verdict |
|---|---|---|
| GILD→2.0% solo | 0.895 | veto |
| + SPGI→3.1% (beta 1.105) | 0.896 | veto |
| + V→3.8% (beta 0.784) | 0.894 | veto + single-name cap |
| + ETN→3.4% (beta 1.24) | 0.897 | veto — the lever I've killed 5x |
| + SPY trim→78% | 0.890 | WORSE + SPY cap |
The reason topping a financial doesn't work: we fund from cash (1.6%, none to spare), so a resize-up just adds beta-<1.0 dollars to a sub-1.0 book — net beta still falls when GILD's beta-0.33 dollars go in. Trimming the SPY-1.0 core to fund a beta-0.33 name makes it worse, not better. The arithmetic only clears one way: a genuinely high-beta NEW active name (>1.2) at fresh size, seated with the defensive leg so the pair nets ≥0.90.
Chair call: I file nothing on the low-vol side this morning. Not a WATCH dressed up as discipline — a tested verdict. The frame (Priya 06-22: reals 2.23 fresh cycle high, low-vol ON, no turn) says keep adding cash-flow defensives, but the floor is a hard structural wall and I will not manufacture beta room by leaning the ETN lever into cycle-high reals and a drained VIX. That's the wrong factor at the wrong time, same as #44/#45/#52/#54.
The ask, restated to Margaret, on the record: the campaign is stuck at 10 names against an 18-name floor only because we have no high-beta quality leg to pair against. Source me a quality cyclical or higher-beta financial (beta ≥1.15, conviction ≥3, the cash-flow-yield theme intact) and I size+pair it with GILD's second 1.0% the day it lands — that single name unlocks two adds, not one. Until then the second GILD leg stays pre-committed and unfiled.
Priya, Iris — same floor open to you. No trades from me this session.
Daniel handed me the explicit ask: source a quality cyclical or higher-beta financial (β≥1.15, conv≥3) so GILD's pre-committed second 1.0% can seat without faking beta off the ETN lever. I worked four candidates to the filings and the live tape, and the honest answer is I file nothing today — not for lack of a thesis, for lack of a buyable high-beta name this morning.
GS — the math works, the tape doesn't. Goldman is a genuine franchise (FY25 SEC XBRL: net income $17.2B, diluted EPS $51.32, ROE ~14.5%) and at beta 1.291 it's enough to unlock the floor — the basket GILD→2.0% + GS 2.0% clears at book beta 0.9005, just over the line. But GS closed $1,096.56 on 06-18, up 22.4% over the window, sitting at its 52-week high. That is a chase, not a dislocation. "Tape divorced from franchise" does not describe a name up 22% in two months — same reason I won't touch ABBV up here. Pass.
FDX — the right kind of name, wrong day. FedEx is beta 1.299 and, unlike GS, genuinely cheap: forward PE ~14.8, EV/EBITDA ~10, FY25 operating cash flow $7.0B (SEC XBRL), four straight beats running +5% to +26%. This is exactly the high-beta quality cyclical the campaign needs. But it prints fiscal Q4 tomorrow, 06-23 (est EPS $5.95) — I do not open a new position the night before a binary print. Filed a conviction-3 thesis; revisit AFTER the print. A soft-quarter gap toward the high-$280s/$290s (where it traded on 05-04's capitulation) is the entry, and it would seat GILD's leg cleanly. SCHW (β0.77) and APD (β0.75) don't clear the floor requirement; EMR (β1.25) is quality but 34x trailing — no dislocation.
BMY — my actual conviction-add today, blocked only by the floor. Bristol closed $54.00 on 06-18, a fresh low, on a 31.7M-share capitulation day (vs ~10M typical). FY25 OCF $14.16B, forward ~9x, 4.5% yield, beta 0.24 — the drawdown is the tape, not the thesis; nothing in the franchise or cash generation broke. But at beta 0.26, topping it pushes the book under 0.90, so it rides only paired with the high-beta unlock I don't have. I table it as defended carry at 2.34%, conviction 4 — kill if FY26 OCF prints below $11B, stop -15% relative, print 07-30.
Net for the vote: GILD's second 1.0% stays pre-committed and unfiled. The wall is the 0.90 floor plus the absence of a buyable high-beta name — not selection. I won't manufacture room off the ETN lever into reals at a 2.23 cycle high. The name to watch hardest now is FDX, post-print.
PROPOSE #52 (chair). I file nothing this morning. Not a dodge — a tested verdict, and it's the same wall I documented in #51 against the live book (beta 0.9018, on the 0.90 floor).
What changed since #51: nothing that unlocks. Margaret worked four high-beta candidates to the filings and live tape and filed zero — correctly. GS clears the math (GILD→2.0% + GS 2.0% lands ~0.9005) but it's at its 52w high, +22% in two months; that's a chase, not a dislocation, and I won't seat the beta unlock on a name I'd have to mark down on the first pullback. FDX is the right name — β1.299, fwd PE ~14.8, four straight beats — but it prints fiscal Q4 tomorrow, 06-23, est EPS $5.95 (confirmed via corporate events). That's binary, and the earnings-gap freeze blocks opening it tonight regardless. EMR is quality but 34x trailing — no dislocation. SCHW/APD don't clear the floor.
The structural fact, restated for the record: GILD's second 1.0% and every other low-vol leg (GIS, BMY) is a sub-0.40-beta name. We fund from cash (1.6%, none to spare), so the only clearing path is a genuinely high-beta NEW active name (β≥1.15) seated WITH the defensive leg. Topping a sub-1.0 financial from cash adds beta-<1.0 dollars; trimming the SPY-1.0 core to fund a beta-0.33 name makes beta worse. I will not fake the offset off the ETN lever into reals 2.23 cycle-high + VIX 16.8 — I've killed that lever five times and the frame (Priya 06-22: low-vol ON, no turn) says keep killing it.
The campaign is paused at 10/18 for one reason only: no buyable high-beta quality pair exists this morning. It is not a thesis gap and not a sizing gap — it's a tape gap. The disciplined move is to wait, not to manufacture a trade.
Pre-commits stand, both with concrete triggers:
- FDX post-print (06-23). If it gaps soft toward high-$280s/$290s (where it traded 05-04), that's the entry — β1.299 unlocks GILD's leg cleanly, and I size+pair the two the same session. If it gaps up on a beat, it goes back on the GS pile: want a pullback, not the high.
- GILD's second 1.0% stays pre-committed and unfiled — seats the day a high-beta quality name lands.
Triggers unchanged: OAS>350 → trim the cyclical leg first; reals<1.90 + 10yr<4.30 → eases low-vol and migrates the ETN lever to the right side. Carry the book as-is.
I file no name — selection is Margaret's and Daniel's lane, and they ran the discipline correctly this morning. My PROPOSE job is to confirm the frame the room is sizing against and back or block the structure. Frame holds, unchanged from FRAME 06-22: 10-year reals 2.23, fresh cycle high (low-vol firmly ON, nowhere near my 1.90 ease trigger); 2s10s flattened to 27bps (cuts pulled forward, not growth); OAS 263, tightest of the cycle, dead complacent; VIX 16.8, June pop fully drained; WTI $84.65, the energy hedge deflating. That's reals up AND credit more complacent AND vol gone — textbook late-cycle squeeze, not a turn.
On the live proposal — I endorse filing nothing. Margaret and Daniel walked the same wall I keep naming: book beta 0.9018, pinned on the 0.90 floor. GILD's pre-committed second 1.0% is a sub-0.40-beta defensive, and there is no buyable β≥1.15 quality cyclical on the tape today — GS is up 22% at its 52w high (a chase, not a dislocation), FDX is the right name but prints fiscal Q4 tomorrow and the earnings-gap freeze blocks it tonight. The campaign pausing at 10/18 is a tape gap, not a thesis or sizing gap. Waiting is the disciplined move.
The one thing I will not have faked: beta room off the ETN lever into reals at a fresh cycle high and VIX 16.8. That's the wrong factor at the wrong time, and Daniel has killed it correctly five times. The honest funding source for the next low-vol leg remains the 79.5% SPY core (the -102bps inception drag), not the high-beta ETN. When a real β≥1.15 quality name lands — FDX post-print, or GS on a genuine pullback — it unlocks GILD's second 1.0% the same session, sized and paired. Until then, carry as-is.
No name on the floor — Margaret, Daniel, and Priya all filed zero this morning, and they're right to. There's nothing to gate and nothing to vote, so I'm not going to manufacture a concern. I'll leave the binding constraints named on the record instead.
Two operative numbers, both read fresh off the live gate. Cash is 1.55%, under the 2% floor by ~45bps — about $4.4k short. The direction-aware gate won't catch a name that nets cash-positive, but any net-buy worsens it and trips. That's the constraint, not single-name room. And beta is 0.9018, dead on the 0.90 floor — every sub-1.0 defensive name the frame wants (GILD 0.33, BMY 0.26, GIS -0.03) drags the book under. The unlock is a new β≥1.15 active name seated alongside the defensive leg, not the ETN lever into reals at a 2.23 cycle high. The non-file is the disciplined move; I won't ask the room to fake beta room to seat a name.
What I lose if we do nothing this week: nothing — the book doesn't trade between sit-downs, so the only cost of waiting is opportunity, and there's no buyable pair to forgo. Single-name cap is quiet: V at 3.11% is the largest active, ~39bps of headroom to the 3.5% cap, nothing creeping.
My ungated judgment carries are unchanged from this morning's frame — Financials at 18.3% / +5.3pp / ~1.4x SPY is still the biggest sector bet and the biggest drag (-14.6bps active inception, ~0.2x from the 1.6x cap), and CME at -6.39% sits ~1360bps from the -2000bps review trip. No new flag — conditions haven't changed, and I don't pile on a standing concern. With nothing on the floor I abstain.
VOTE: abstain
DISCUSS. One item on the floor — the pending GILD 1.0% starter, already in. No new name filed this morning: Margaret worked four high-beta candidates to the tape and filed zero, correctly. The wall is unchanged — beta 0.9018 pinned on the 0.90 floor, no buyable high-beta pair to unlock GILD's second leg. We debate the carry and the pre-commits, then vote. Margaret, take it.
DISCUSS — the one floor item is the GILD 1.0% starter (#60), already seated. Confirmed live: 79 sh, 0.99% weight, -0.36% since entry, +0.7bps active. The trade is the cash-flow-yield defensive Margaret leads — FY25 39% op margin, $10B OCF, ROE 43%, fwd PE ~15, beta 0.332. Catalyst is the 08-06 print; near-term it's carry, not a pop. Stop -15% relative, kill on FY26 OCF <$11B. Size is 1.0% by force, not choice: the second pre-committed 1.0% needs a β≥1.15 active name to offset, and the floor's pinned at 0.9018 — Margaret sourced none today (GS a chase at 52w high, FDX prints 06-23). So the starter stands solo, no faked ETN beta into reals 2.23. open for discussion.
The GILD starter is already on the book and confirmed — 79 shares, ~0.99% weight, -0.36% since entry, +0.7bps active, beta 0.332. There's nothing live to vote here; it's a carry. My franchise read is unchanged from sponsorship: FY25 SEC XBRL shows rev $29.4B, op income $10.0B = 39% op margin, OCF $10.0B, ROE 43%, fwd PE ~15, 2.6% covered yield. This is the right cash-flow-yield defensive for Priya's tape — reals 2.23 fresh cycle high, OAS 263 dead complacent. Approve the carry.
The second 1.0% stays pre-committed and unfiled. It seats only paired with a buyable β≥1.15 name, and I worked four candidates to the filings and the live tape this morning and have none I'll sign: GS clears the math but sits at its 52w high (+22% in two months — a chase, not a dislocation); FDX is the right name (β1.299, fwd ~14.8x, FY25 OCF $7.0B, four straight beats) but prints fiscal Q4 tomorrow 06-23, est $5.95 — I don't open into a binary. Kill GILD if FY26 OCF <$11B; stop -15% rel; print 08-06. FDX post-print — a soft-quarter gap to the high-$280s — is the entry I'm watching hardest, and it unlocks the second leg cleanly.
GILD #60 is already seated and a carry — 79 sh, ~0.99%, -0.36% since entry, beta 0.332. Nothing new to size; I'm confirming the frame the room built it on. Reals at a fresh cycle-high 2.23, 2s10s flat at 27bps, OAS 263 dead-complacent, VIX 16.8 — low-vol firmly ON, nowhere near my 1.90 ease trigger. A beta-0.33 cash-flow defensive at 39% op margin and $10B OCF is exactly the right factor for this tape: own cash today, not multiple later. The -0.36% is tape, not thesis. The second 1.0% stays pre-committed and unfiled until a buyable β≥1.15 quality cyclical lands — FDX post-print 06-23 or GS on a real pullback. I will not fake the beta offset off the ETN lever into reals at a cycle high with VIX 16.8. Back the carry.
The GILD 1.0% starter (#60) is already seated and confirmed — 79 sh, ~0.99% weight, beta 0.332, -0.36% since entry, +0.7bps active. It's a carry, not a live trade, so there's nothing new to gate.
Loss path for the record: a -15% gap on ~$9.7k of NAV costs us about $1.5k, ~15bps. Print is 08-06, outside the holding window; the relative stop caps the rest. Bounded and wearable, no breached limit on the name.
Constraints unchanged from this morning, both ungated by the single-name cap: cash 1.55%, ~45bps under the 2% floor; beta 0.9018, dead on the 0.90 floor. Neither is GILD's doing. Default approve.
VOTE: approve
no orders. the gild 1.0% item is already on the book from the 06-18 sequence — 79.02 sh, 0.99pct weight, carry not a live trade, so zero fills today. book steady at 10 active, nav 985,438.86, beta 0.9018 pinned on the 0.90 floor. cash 15,324 = 1.56pct, still ~44bps short of the 2pct floor, iris flag 21 carries. no name in t+1 earnings freeze. no rejects, halts, breaks, residual.
VOTE. One item on the floor: GILD proposal #61 — the 1.0% starter already seated (#60, 79 sh, ~0.99% weight, beta 0.332, -0.36% since entry, +0.7bps active). This is a ratification of a carry, not a new fill. No high-beta unlock landed, so GILD's pre-committed second 1.0% stays unfiled; the wall holds — beta 0.9018 pinned on the 0.90 floor.
The vote, in order:
- Margaret — AYE. Sponsor. FY25 franchise intact (39% op margin, $10B OCF, ROE 43%, fwd PE ~15); cash-flow-yield defensive, the right theme for the tape.
- Daniel (chair) — AYE. Half-size is the honest size; advances the campaign 9→10 toward the 18-name floor with no faked beta. Second 1.0% pre-committed to the day a β≥1.15 quality name lands.
- Priya — AYE. Frame confirms: reals 2.23 cycle high, OAS 263, VIX 16.8 — low-vol ON, beta 0.332 sits right in the late-cycle defensive sleeve.
- Iris — AYE. Clean gate; loss path bounded (~$1.5k / ~15bps on a -15% gap), no breach.
Carried 4-0. GILD #61 ratified as carry. Pre-commits stand: FDX post-print 06-23 (soft gap high-$280s/$290s = entry, unlocks GILD's leg + sizes/pairs same session; gap-up beat → GS pile on a pullback). Triggers unchanged: OAS>350 trim cyclical first; reals<1.90 + 10yr<4.30 ease low-vol and migrate the ETN lever right-side. Next catalyst is the FDX open tomorrow.
GILD #61 is a ratification of the 1.0% starter already on the book — 79 sh, ~0.99% weight, beta 0.332, -0.36% since entry, +0.7bps active. My franchise read is unchanged from sponsorship: FY25 39% op margin, $10.0B OCF, ROE 43%, fwd PE ~15, 2.6% yield, bought through the 200d. It's the cash-flow-yield defensive the frame wants, and nothing broke. No new fill, no faked beta, no high-beta unlock to seat the second leg — the wall stays the 0.90 floor, not the thesis. Easy aye on the carry.
VOTE: approve
VOTE (chair) on GILD #61. This ratifies the already-seated 1.0% starter (#60: 79 sh, ~0.99% weight, beta 0.332, -0.36% since entry, +0.7bps active) — a carry, not a new fill. Franchise is intact (FY25 39% op margin, $10B OCF, ROE 43%, fwd PE ~15, beta 0.332) and the frame backs it (Priya 06-22: reals 2.23 cycle high, OAS 263, VIX 16.8 — low-vol ON). Book unchanged: 10 active, beta 0.9018 on the 0.90 floor, cash 1.56%. GILD's second 1.0% stays pre-committed/unfiled until a β≥1.15 quality name seats with it. Next catalyst: FDX fiscal Q4 print tomorrow 06-23 (est $5.95) — soft gap high-$280s/$290s = entry + unlocks GILD's leg same session.
VOTE: approve
GILD #61 ratifies the seated 1.0% starter (#60: 79 sh, ~0.99%, beta 0.332, -0.36% since entry, +0.7bps active) — a carry, no new fill. The frame I confirmed this morning backs it cleanly: reals 2.23 at a fresh cycle high (low-vol firmly ON), 2s10s 27 flattening, OAS 263 the most complacent of the cycle, VIX 16.8. A beta-0.33 cash-flow defensive — 39% op margin, $10B OCF, ROE 43%, fwd PE ~15 — is exactly the factor this tape wants: own cash today, not multiple later. The -0.36% is tape, not thesis. Second 1.0% stays pre-committed and unfiled until a buyable β≥1.15 quality cyclical seats with it; no faked beta off the ETN lever into reals at cycle high.
VOTE: approve
GILD #61 is a ratification of the seated 1.0% starter (#60: 79 sh, ~0.99% weight, beta 0.332, -0.36% since entry, +0.7bps active) — a carry, not a new fill, so nothing new to gate today.
Loss path for the record: a -15% gap on ~$9.7k of NAV costs about $1.5k, ~15bps. Print 08-06 is outside the holding window and the relative stop caps the bleed. Bounded, wearable, no breached limit.
Operative constraints unchanged and not GILD's doing: cash 1.56% sits ~44bps under the 2% floor, beta 0.9018 pinned dead on the 0.90 floor. The structural wall holds — the second 1.0% needs a NEW beta-1.15 active name seated alongside the defensive leg, and Margaret correctly filed none this morning.
VOTE: approve
CLOSE (chair) 06-22. Frame: late-cycle defensive, reals at a fresh cycle-high 2.23, 2s10s flat 27bps, OAS 263 dead-complacent, VIX 16.8 — low-vol firmly ON, no turn (Priya 06-22). Voted in: GILD #61, carried 4-0 — but read it for what it is, a ratification of the already-seated 1.0% starter (#60: 79 sh, ~0.99%, beta 0.332, -0.36%, +0.7bps active), a carry, not a new fill. Vetoed/filed nothing else: Margaret worked GS (52w-high chase), FDX (prints 06-23, binary), EMR (no dislocation), SCHW/APD (below floor) to zero — correctly. Book unchanged: 10 active, NAV 985.4K, beta 0.9018 pinned on the 0.90 floor, cash 1.56%. Open item, not a flag: the structural wall stands — GILD's 2nd 1.0% stays pre-committed/unfiled until a β≥1.15 quality name seats with it. Next catalyst is FDX fiscal Q4 tomorrow (est $5.95): soft gap high-$280s/$290s = entry + unlocks GILD's leg same session; gap-up beat → GS on a pullback, not the high. Triggers: OAS>350 trim cyclical first; reals<1.90 + 10yr<4.30 ease low-vol + migrate ETN right-side. Lena — minutes, please.
10:00, Monday, 22 June 2026.
They voted to ratify a seat already filled. GILD proposal #61 carried 4-0 [turns 560–563], but read it for what it is: a bookkeeping motion on a 1.0% starter that printed three days ago (79 shares @ $124.21, now -0.36% since entry, +0.7bps active contribution). Margaret sponsored it [turn 560] on the franchise — FY25 operating margin 39%, $10B cash flow, ROE 43%, forward PE around 15 — and the room nodded it through in four ayes without debate. Daniel [turn 561] called it "half-size is the honest size," because the 2.0% conviction weight won't clear the 0.90 beta floor and he's killed the ETN lever five times now on his own triggers. Priya [turn 562] confirmed the frame: reals at a fresh cycle-high 2.23, low-vol firmly ON. Iris [turn 563] bounded the loss path at about $1.5k on a -15% gap. Seventeen minutes, gavel [turn 564].
The real agenda was the thing they didn't vote on. Margaret worked four high-beta candidates to unlock GILD's second 1.0% — GS (sitting at its 52-week high, +22% in two months, "a chase, not a dislocation"), FDX (the right name at the right price but it prints fiscal Q4 tomorrow so the earnings-gap freeze blocks it tonight), EMR (no dislocation at 34x), SCHW and APD (don't clear the beta floor). She filed zero [turn 554]. Daniel ran the full gate against the live book [turn 553] and every path that tops GILD or another low-vol name solo pushes beta under 0.90 — the only clearing structure is a NEW high-beta active name (β≥1.15) seated WITH the defensive leg, and it isn't sourced yet. So GILD's second 1.0% stays "pre-committed and unfiled" (Daniel's phrase from three bulletins now), and the campaign toward 18 names pauses at ten.
The discipline is this: they didn't fake beta room with the ETN lever into cycle-high reals, and they didn't chase GS at a 52-week high because the math clears. They sized what the floor allowed and tabled the rest. You watch enough of these and the veto comes before the vote — this one came three days ago, and today was just the paperwork.
Book to ten active names, NAV $985.4K, beta 0.9018 on the 0.90 floor for the fifth straight session, SPY at 79.5%. The unlock to watch: FDX prints tomorrow (est $5.95); a soft-quarter gap toward the high-$280s unlocks GILD's leg and they size+pair it same session. A gap-up beat sends them back to the GS pile, but they want a pullback, not the high. Frame unchanged, low-vol ON, campaign paused on a tape gap.